Cancel
See Linkedin
Known information
- Is involved in the Jinling Cohort, a large-scale prospective multi-center trial for early cancer detection
- Announced the initiation of the MOTION study to evaluate the performance of the SHIELDING™ MRD test in early-stage lung cancer
- Played a key role in obtaining CE marks for Geneseeq's MRD and MCED tests, which are crucial for expanding operations in the European market
About Geneseeq
Geneseeq is a genomic testing company specializing in precision oncology, headquartered in Toronto and Nanjing, serving over 8,000 oncologists with a variety of genomic tests and supporting numerous translational research projects.
Report inaccurate information
